ISSN: 1838-7640Theranostics
Global reach, higher impact
Theranostics 2020; 10(12):5530-5531. doi:10.7150/thno.46662 This issue Cite
Erratum
Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum
Suoyuan Li1,4*, Tao Zhang1*, Weiguo Xu2*, Jianxun Ding2, 
, Fei Yin3, Jing Xu3, Wei Sun1, Hongsheng Wang3, Mengxiong Sun1, Zhengdong Cai1,3, , Yingqi Hua1,3,
1. Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, P. R. China
2. Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, P. R. China
3. Shanghai Bone Tumor Institution, Shanghai 201620, P. R. China
4. Department of Orthopedics, Suzhou Municipal Hospital, Nanjing Medical University, Suzhou 215000, P. R. China
*These authors contributed equally to this work.
Citation:
Li S, Zhang T, Xu W, Ding J, Yin F, Xu J, Sun W, Wang H, Sun M, Cai Z, Hua Y. Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum. Theranostics 2020; 10(12):5530-5531. doi:10.7150/thno.46662. https://www.thno.org/v10p5530.htm
Other stylesCorrected-article in Theranostics, Volume 8, 1361
In the initially published version of this article [1], the marker “E” was missed in Figure 3E, the Western blot bands were incorrectly displayed in Figure 5F, and the values on the ordinate were incorrectly labeled in Figure 6C.
The corrected Figure 3E, Figure 5F, and Figure 6C are as follows:
Figure 3
(E) Semiquantitative analysis of Western blot bands RIP1, RIP3, PARP, caspase-3, and caspase-8.
Figure 5
(F) RIP1, RIP3, PARP, caspase-3, and caspase-8 expression in primary tumor tissues per group detected by Western blot.
Figure 6
(C) Average microscopically counted lung metastases from largest coronal sections.
The corrections made in this erratum do not affect the original conclusions. The authors apologize for any inconvenience or misunderstanding that these errors may have caused.
References
1. Li S, Zhang T, Xu W, Ding J, Yin F, Xu J, Sun W, Wang H, Sun M, Cai Z, Hua Y. Sarcoma-targeting peptide-decorated polypeptide nanogel intracellularly delivers shikonin for upregulated osteosarcoma necroptosis and diminished pulmonary metastasis. Theranostics. 2018;8(5):1361-1375 doi: 10.7150/thno.18299
Author contact
Corresponding author: Yingqi Hua, E-mail: yhuaedu.cn; Jianxun Ding, E-mail: jxdingac.cn; Zhengdong Cai, E-mail: czd856163.com.
Published 2020-4-12
Citation styles
APA
Li, S., Zhang, T., Xu, W., Ding, J., Yin, F., Xu, J., Sun, W., Wang, H., Sun, M., Cai, Z., Hua, Y. (2020). Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum. Theranostics, 10(12), 5530-5531. https://doi.org/10.7150/thno.46662.
ACS
Li, S.; Zhang, T.; Xu, W.; Ding, J.; Yin, F.; Xu, J.; Sun, W.; Wang, H.; Sun, M.; Cai, Z.; Hua, Y. Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum. Theranostics 2020, 10 (12), 5530-5531. DOI: 10.7150/thno.46662.
NLM
Li S, Zhang T, Xu W, Ding J, Yin F, Xu J, Sun W, Wang H, Sun M, Cai Z, Hua Y. Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum. Theranostics 2020; 10(12):5530-5531. doi:10.7150/thno.46662. https://www.thno.org/v10p5530.htm
CSE
Li S, Zhang T, Xu W, Ding J, Yin F, Xu J, Sun W, Wang H, Sun M, Cai Z, Hua Y. 2020. Sarcoma-Targeting Peptide-Decorated Polypeptide Nanogel Intracellularly Delivers Shikonin for Upregulated Osteosarcoma Necroptosis and Diminished Pulmonary Metastasis: Erratum. Theranostics. 10(12):5530-5531.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.